TY  - JOUR
AU  - Pérez Cano, Rosa
AU  - Vranckx, J.J.
AU  - Lasso Vázquez, José María
AU  - Calabrese, C.
AU  - Merck, B.
AU  - Milstein, A.M.
AU  - Sassoon, E.
AU  - Delay, E.
AU  - Weiler-Mithoff, E.M.
PY  - 2012
DO  - 10.1016/j.ejso.2012.02.178
SN  - 0748-7983
UR  - https://hdl.handle.net/20.500.14352/131817
T2  - European Journal of Surgical Oncology
AB  - Aims:Women undergoing breast conservation therapy (BCT) for breast cancer are often left with contour defects and few acceptable reconstructive options. RESTORE-2 is the first prospective clinical trial using autologous adipose-derived regenerative...
LA  - eng
M2  - 382
PB  - Elsevier
KW  - Mammaplasty [E04.680.500]
KW  - Transplantation; Autologous [E04.936.664]
KW  - Mesenchymal stem cell transplantation [E04.936.225.687.625]
KW  - Carcinoma
KW  - Ductal
KW  - Breast [C04.588.180.390]
KW  - Mastectomy
KW  - Segmental [E04.466.701]
KW  - Subcutaneous fat [A10.165.114.830.750]
TI  - Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial
TY  - journal article
VL  - 38
ER  -